Conditioned nutritional deficiencies in the cardiomyopathic hamster heart

Canadian Journal of Cardiology

Volumn 17, Issue 4, 2001, Pages 449-458

  Keith, M E ^a   Ball, A ^a   Jeejeebhoy, K N ^a   Kurian, R ^a   Butany, J ^a   Dawood, F ^a   Wen, W H ^a   Madapallimattam, A ^a   Sole, M J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Antioxidants; Cardiomyopathy; Congestive heart failure; Hemodynamics; Myocardium; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARNITINE; CREATINE; CYSTEINE; ISOPROSTANE; SELENIUM; TAURINE; THIAMINE; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; CELL ENERGY; CELL STRUCTURE; CONTROLLED STUDY; DEPLETION; DIET SUPPLEMENTATION; DISEASE COURSE; ELECTRON MICROSCOPY; FUNCTIONAL ASSESSMENT; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEMODYNAMICS; MALE; NONHUMAN; NUTRITION; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OXIDATIVE STRESS; SYRIAN HAMSTER; TISSUE LEVEL;

ANIMALS; CARDIOMYOPATHY, DILATED; CRICETINAE; DIETARY SUPPLEMENTS; HEART FUNCTION TESTS; MALE; MESOCRICETUS; NUTRITIONAL STATUS; UBIQUINONE; VITAMIN E;

EID: 0035024774     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Tumor necrosis factor and steroid metabolism in chronic heart failure: Possible relationship to muscle wasting
2. Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure - Effects of long-term dietary supplementation
3. S 31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure
4. Increased oxidative stress in patients with congestive heart failure
5. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
6. Deficiency of coenzyme 10 in myocardial failure
7. Coenzyme Q10 attenuates the progression of cardiomyopathy in hamsters
8. Metabolic alterations in end-stage and less severe heart failure - Myocardial carnitine disease
9. Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure
10. Cardiac carnitine deficiency and altered carnitine transport in CM hamsters
11. L-carnitine treatment for congestive heart failure - Experimental and clinical study
12. The creatine kinase system in normal and diseased human myocardium
13. Creatine kinase system in the failing and nonfailing human myocardium
14. Mechanisms of amino acid release from the isolated anoxic/reperfused rat heart
15. Effects of taurine on heart calcium in the CM hamster
16. Nutritional, hepatic, and metabolic effects of cachectin/tumor necrosis factor in rats receiving total parenteral nutrition
17. Lactose protects against estrogen-induced pigment gallstones in hamsters fed nutritionally adequate purified diets
18. High performance liquid chromatography of coenzyme Q-related compounds and its application to biological materials
19. Amino acid analysis utilizing phenylisothiocyanate derivatives
20. Rapid spectrophotometric determination of plasma carnitine concentrations
21. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by HPLC
22. Vitamin E supplementation in cystic fibrosis
23. Comparative sensitivities of tocopherol levels of platelets, red blood cells and plasma for estimating vitamin E nutritional status in the rat
24. Carnitine deficiency syndromes and lipid storage myopathies
25. Alterations of ventricular contractility and myofibrillar loss in taurine deficient hearts
26. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10
27. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure
28. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure
29. Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts
30. The contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied heart
31. Regulation of fatty acid oxidation in the mammalian heart in health and disease
32. Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure
33. Myocardial carnitine deficiency in chronic heart failure
34. Changes in tissue levels of carnitine and other metabolites during ischemia and anoxia
35. Protection of the ischemic dog myocardium with carnitine
36. Carnitine derivatives in heredity CM animals
37. Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy
38. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: The L-carnitine echocardiografia digitalizzata infarto miocardico (CEDIM) trial
39. Protection of the myocardium during ischemic arrest: Possible toxicity of carnitine in cardioplegic solutions
40. Inhibition of carnitine synthesis protects against left ventricular dysfunction in rats with myocardial ischemia
41. Microvascular spasm in the CM Syrian hamster: A preventable cause of focal myocardial necrosis
42. Oxy free radical system in heart failure and therapeutic role of oral vitamin E
43. Role of oxidative stress in the transition from hypertrophy to heart failure
44. Oxidative stress and the pathogenesis of heart failure
45. Vitamin E and oxidative stress in the heart of the CM syrian hamster
46. Prophylaxis by taurine in the hearts of CM hamsters
47. Taurine depletion, a novel mechanism for cardioprotection from regional ischemia
48. Cardiac actions of taurine as modulator of the ion channels